On April 1, 2026, China implemented a landmark national standard: Classification and Determination of TCM Constitution. Although designated as a recommended rather than mandatory standard, it represents a major step in modernizing traditional Chinese medicine (TCM) by converting traditional constitution theory into a clear, measurable and clinically practical framework. By clarifying the relationship between constitution, disease, and pattern differentiation, the standard strengthens professional credibility, supports research, and enhances patient-centered treatment.
Patrick Johnson
Patrick Johnson is the CEO of BioPhotas, Inc., and the inventor of the award-winning Celluma series of light therapy devices. He has served as a senior executive in medical device companies, both public and private, for more than 20 years. Considered an authority on the science of light therapy, his expertise is sought after worldwide. For more information about Celluma, visit www.celluma.com.